Chemically encoded spatially addressed library screening platforms

US11015265B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11015265-B2
Application numberUS-202016940499-A
CountryUS
Kind codeB2
Filing dateJul 28, 2020
Priority dateFeb 24, 2015
Publication dateMay 25, 2021
Grant dateMay 25, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are encoded split pool libraries useful, inter alia, for forming highly diverse and dense arrays for screening and detection of a variety of molecules.

First claim

Opening claim text (preview).

What is claimed is: 1. A microparticle immobilized on a solid support, wherein said microparticle is covalently attached to: (i) a ligand domain through a first linker; and (ii) a nucleic acid domain through a second linker, wherein said ligand domain is a peptide, and wherein said peptide comprises at least one moiety selected from the group consisting of a naturally occurring amino acid, a non-naturally occurring amino acid, and a mimetic of a naturally occurring amino acid; wherein said nucleic acid domain identifies said ligand domain; wherein said second linker comprises an acyl group, a sulfonamide group, or a photocleavable group; and wherein said second linker is cleavable under a condition that does not cleave said first linker. 2. The microparticle of claim 1 , wherein said ligand domain comprises a removable protecting moiety covalently attached to a reactive moiety. 3. The microparticle of claim 2 , wherein said reactive moiety is selected from the group consisting of a carboxylic acid, an amine, a thiol, or an alcohol. 4. The microparticle of claim 2 , wherein said removable protecting moiety comprises an amino acid side chain, an amino terminus, or a carboxy terminus. 5. The microparticle of claim 1 , wherein said microparticle is selected from the group consisting of a functionalized microbead, a magnetic microbead, a metallic microbead, a silica microbead, a polymeric microbead, a dendrimer, and a branched polymer. 6. The microparticle of claim 1 , wherein said peptide is selected from the group consisting of a macrocyclic peptide, an acyclic precursor to a macrocyclic peptide, a peptidomimetic, a polyamide, and a macrolactam. 7. The microparticle of claim 1 , wherein said peptide further comprises non-peptide functionality. 8. The microparticle of claim 1 , wherein said ligand domain is bound to a ligand binder. 9. The microparticle of claim 1 , wherein said ligand domain comprises a plurality of ligand domains attached through a plurality of first linkers. 10. The microparticle of claim 1 , wherein said nucleic acid domain comprises a plurality of nucleic acid domains attached through a plurality of second linkers. 11. The microparticle of claim 1 , wherein said nucleic acid sequence is bound to a detectably labeled complementary nucleic acid sequence. 12. A high density ordered array, said high density ordered array comprising a solid support comprising a plurality of wells, wherein each of said plurality of wells further comprises an immobilized microparticle, and wherein said immobilized microparticle is covalently attached to: (i) a ligand domain through a first linker; and (ii) a nucleic acid domain through a second linker; wherein said ligand domain is a peptide, and wherein said peptide comprises at least one moiety selected from the group consisting of a naturally occurring amino acid, a non-naturally occurring amino acid, and a mimetic of a naturally occurring amino acid; wherein said nucleic acid domain identifies said ligand domain; wherein said second linker comprises an acyl group, a sulfonamide group, or a photocleavable group; wherein said second linker is cleavable under a condition that does not cleave said first linker; and wherein said high density ordered array comprises at least about 50,000 microparticles per square millimeter. 13. The high density ordered array of claim 12 , wherein said ligand domain comprises a removable protecting moiety attached to a reactive moiety. 14. The high density ordered array of claim 12 , wherein said ligand domain is bound to a ligand binder. 15. The high density ordered array of claim 12 , wherein said wherein said peptide is selected from the group consisting of a macrocyclic peptide, an acyclic precursor to a macrocyclic peptide, a peptidomimetic, a polyamide, and a macrolactam. 16. The high density ordered array of claim 12 , wherein said peptide further comprises non-peptide functionality. 17. The high density ordered array of claim 12 , wherein said high density includes at least about 150,000 microparticles per square millimeter. 18. The high density ordered array of claim 17 , wherein said high density ordered array includes at least about 250,000 microparticles per square millimeter. 19. The high density ordered array of claim 12 , wherein said high density ordered array comprises between 10 6 to 10 11 of said immobilized microparticles. 20. The high density ordered array of claim 12 , wherein said condition is selected from the group consisting of UV irradiation, light irradiation, trifluoroacetic acid, ammonium hydroxide, ammonia, methylamine, and a mixture of ammonium hydroxide and methylamine. 21. The high density ordered array of claim 12 , wherein said high density ordered array is a square packed array or a hexagonal array.

Assignees

Inventors

Classifications

  • C40B70/00Primary

    Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes · CPC title

  • Magnetic particles · CPC title

  • with ligand attached to the carrier via a chemical coupling agent (coatings G01N33/54393) · CPC title

  • Libraries containing peptides or polypeptides, or derivatives thereof · CPC title

  • Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11015265B2 cover?
Provided herein are encoded split pool libraries useful, inter alia, for forming highly diverse and dense arrays for screening and detection of a variety of molecules.
Who is the assignee on this patent?
Hope City
What technology area does this patent fall under?
Primary CPC classification C40B70/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).